Liezl Gambe

Menlo Park, California-based Personalis (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, reported unaudited preliminary financial and operational results for the fourth quarter and full year ended December 31, 2025.

Neogen (NASDAQ:NEOG) shares are in focus after the food and animal safety leader reported second-quarter revenue of $224.7 million, a 2.8% decline from the previous year.

Shares of software supply chain platform JFrog (NASDAQ:FROG) fell 4.7% in morning trading on January 8, 2026, as part of a broader market rotation out of the technology sector.

The decline came amid profit-taking in high-growth tech stocks following a strong recent rally, particularly in artificial-intelligence-related names.

Northern Technologies International Corporation (NASDAQ:NTIC) reported consolidated net sales of $23.309 million for its fiscal first quarter of 2026, a 9.2% increase from the prior-year period and marking a new quarterly record.

Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported positive interim data from its ongoing Phase 1b/2a RESOLVE trial evaluating EP-104GI in patients with eosinophilic esophagitis.

China is preparing to approve the import of Nvidia Corp.’s (NASDAQ:NVDA) H200 artificial intelligence chips for select commercial customers as soon as this quarter, according to people familiar with the matter.

European Union antitrust enforcers will decide by February 10 whether to approve Alphabet's (NASDAQ:GOOGL) $32 billion acquisition of cybersecurity startup Wiz.

Pharming Group N.V. (NASDAQ:PHAR) reported preliminary, unaudited full-year 2025 revenues of approximately $376 million, topping its own recently elevated guidance and marking a 27% increase over 2024.

Zcash’s core developers have left Electric Coin Company and plan to form a new business following governance disagreements.

Bitcoin’s rally faces a test as strong accumulation meets renewed selling pressure from miners.